XML 60 R23.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue (Tables)
9 Months Ended
Sep. 29, 2024
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue [Table Text Block]
In the following tables, revenue is disaggregated by primary geographical markets and major goods and service lines.
Reportable Segments
Three Months Ended
September 29, 2024October 1, 2023
Life SciencesDiagnosticsTotalLife SciencesDiagnosticsTotal
(In thousands)
Primary geographical markets
Americas$163,071 $139,254 $302,325 $159,916 $133,679 $293,595 
Europe67,708 114,330 182,038 72,638 105,420 178,058 
Asia70,142 129,544 199,686 75,301 123,785 199,086 
$300,921 $383,128 $684,049 $307,855 $362,884 $670,739 
Major goods/service lines
Life Sciences reagents$178,779 $— $178,779 $171,924 $— $171,924 
Life Sciences instruments78,797 — 78,797 89,658 — 89,658 
Life Sciences software43,345 — 43,345 46,273 — 46,273 
Reproductive health— 132,743 132,743 — 123,169 123,169 
Applied genomics— 52,691 52,691 — 53,434 53,434 
Immunodiagnostics— 197,694 197,694 — 186,281 186,281 
$300,921 $383,128 $684,049 $307,855 $362,884 $670,739 

Reportable Segments
Nine Months Ended
September 29, 2024October 1, 2023
Life SciencesDiagnosticsTotalLife SciencesDiagnosticsTotal
(In thousands)
Primary geographical markets
Americas$487,812 $416,650 $904,462 $508,565 $405,885 $914,450 
Europe204,711 340,477 545,188 227,630 326,942 554,572 
Asia225,282 350,722 576,004 236,454 349,194 585,648 
$917,805 $1,107,849 $2,025,654 $972,649 $1,082,021 $2,054,670 
Major goods/service lines
Life Sciences reagents$532,856 $— $532,856 $554,010 $— $554,010 
Life Sciences instruments245,959 — 245,959 285,933 — 285,933 
Life Sciences software138,990 — 138,990 132,706 — 132,706 
Reproductive health— 385,793 385,793 — 373,911 373,911 
Applied genomics— 151,425 151,425 — 175,941 175,941 
Immunodiagnostics— 570,631 570,631 — 532,169 532,169 
$917,805 $1,107,849 $2,025,654 $972,649 $1,082,021 $2,054,670